12 / 40
Page 55
Notes:
conferenceseries
.com
Volume 9
Journal of Clinical & Experimental Cardiology
ISSN: 2155-9880
October 22-24, 2018 | Rome, Italy
27
th
European Cardiology Conference
Euro Cardiology 2018
October 22-24, 2018
Mass media campaign to improve poor diagnosis and poor medical adherence in atrial fibrillation
Jochen Senges
Stiftung Institut für Herzinfarktforschung Ludwigshafen, Germany
A
trial fibrillation (AF) is the most common cardiac rhythm disorder and affects mainly older people. Poor diagnosis of AF:
Large registries (Gloria-AF) have clearly shown that about two-third of patients in Western Europe with newly diagnostic
non-valvular AF are detected asymptomatic/minimally symptomatic. The rate of previous stroke in these patients is more than
twice as high as in symptomatic patients, despite no difference in CHA2DS2-VASc-Score. This may be explained by a longer
but subclinical and therefore undiagnosed AF history. Poor medical adherence: poor medication adherence is the second most
important factor underlying strokes in patients with atrial fibrillation. Various major studies have demonstrated that less than
half of AF-patients are treated with guideline antithrombotic medication. Mass media campaign: these results underline the
importance for both: public programs to detect non-valvular AF in the older population but also public education programs
that should focus on patients’ poor understanding of the importance for sustained antithrombotic medication adherence to
prevent stroke. The ARENA study includes a longstanding mass media campaign over one year to improve diagnosis and
medical adherence in atrial fibrillation. Actually over 10.000 AF-patients are documented, and first results will be presented at
this meeting.
Recent Publications:
1. Puls Miriam, Lubos Edith, Boekstegers Peter, Bardeleben Ralph Stephan von, Ouarrak Taoufik, Butter Christian, et
al., (2016) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice:
results from the German transcatheter mitral valve interventions registry. Eur Heart J 37(8):703–712.
2. Schmidt Martin, Dorwarth Uwe, Andresen Dietrich, Brachmann Johannes, et al., (2016) German ablation registry:
cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation-one-year outcome data. Heart Rhythm
13(4):836–844.
3. Zylla Maura M, Brachmann Johannes, Lewalter Thorsten, Hoffmann Ellen, Kuck Karl-Heinz et al., (2016) Sex-related
outcome of atrial fibrillation ablation - insights from the German ablation registry. Heart Rhythm 13(9):1837–1844.
4. Brachmann Johannes, Lewalter Thorsten, Kuck Karl-Heinz, et al., (2017) Long-term symptom improvement and
patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation
registry. Eur Heart J 38(17):1317–1326.
Biography
Jochen Senges is the Director of the Institute of Herzinfarktforschung Ludwigshafen. He completed his Medical School at University of Heidelberg, Berlin and Frankfurt
1961-1966; Medical Diploma at University of Heidelberg in 1966; Board certification in Internal Medicine in 1974. He was a Senior Staff Physician in Department of
Cardiology, University of Heidelberg. He completed his PhD in Medicine with a neurophysiologic dissertation at University of Heidelberg in 1967 and; was a Research
Fellow at Stanford University, California, USA in 1969. His main research topic is Cardiac Arrhythmias. He was an Associate Professor of the Medical Faculty, University
of Heidelberg in 1981.
Jochen Senges, J Clin Exp Cardiolog 2018, Volume 9
DOI: 10.4172/2155-9880-C10-116